Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Jackson

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2008
Serum-based microRNAs: are we blinded by potential?David B Jackson
Drug Discovery Today|February 10, 2009
Molecular perspectives on the non-responder phenomenonDavid B Jackson
Drug Discovery Today|February 10, 2009
Clinical and economic impact of the nonresponder phenomenon--implications for systems based discoveryDavid B Jackson
Expert Review of Molecular Diagnostics|July 13, 2011
Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicineAlexander Picker, David B Jackson
Gynecologic Oncology|March 27, 2016
Use of "big data" in drug discovery and clinical trialsGuillaume Taglang, David B Jackson
Nature Reviews. Clinical Oncology|October 13, 2011
Personalized cancer medicine--advances and socio-economic challengesDavid B Jackson, Anil K Sood
Healthcare (Basel, Switzerland)|March 22, 2019
Adverse Event Circumstances and the Case of Drug InteractionsTheodoros G Soldatos, David B Jackson
Bioinformatics (Oxford, England)|May 23, 2003
Hierarchical analysis of dependency in metabolic networksJulien Gagneur, David B Jackson, Georg Casari
Journal of Personalized Medicine|September 8, 2019
Precision Oncology-The Quest for EvidenceTheodoros G Soldatos, Sajo Kaduthanam, David B Jackson
EXS|March 5, 2003
BioinformaticsDavid B Jackson, Eric Minch, Robin E Munro
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2008
Serum-based microRNAs: are we blinded by potential?David B Jackson
Drug Discovery Today|February 10, 2009
Molecular perspectives on the non-responder phenomenonDavid B Jackson
Drug Discovery Today|February 10, 2009
Clinical and economic impact of the nonresponder phenomenon--implications for systems based discoveryDavid B Jackson
Expert Review of Molecular Diagnostics|July 13, 2011
Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicineAlexander Picker, David B Jackson
Gynecologic Oncology|March 27, 2016
Use of "big data" in drug discovery and clinical trialsGuillaume Taglang, David B Jackson
Nature Reviews. Clinical Oncology|October 13, 2011
Personalized cancer medicine--advances and socio-economic challengesDavid B Jackson, Anil K Sood
Healthcare (Basel, Switzerland)|March 22, 2019
Adverse Event Circumstances and the Case of Drug InteractionsTheodoros G Soldatos, David B Jackson
Bioinformatics (Oxford, England)|May 23, 2003
Hierarchical analysis of dependency in metabolic networksJulien Gagneur, David B Jackson, Georg Casari
Journal of Personalized Medicine|September 8, 2019
Precision Oncology-The Quest for EvidenceTheodoros G Soldatos, Sajo Kaduthanam, David B Jackson
EXS|March 5, 2003
BioinformaticsDavid B Jackson, Eric Minch, Robin E Munro
Pageof 3